Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

NCT05278208 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

High Grade Glioma
Meningioma
Embryonal Tumor
Medulloblastoma
Anaplastic Ependymoma
Recurrent Diffuse Intrinsic Pontine Glioma
Recurrent Malignant Glioma
Recurrent Medulloblastoma
Recurrent Primary Central Nervous System Neoplasm
Refractory Diffuse Intrinsic Pontine Glioma
Refractory Malignant Glioma
Refractory Medulloblastoma
Refractory Primary Central Nervous System Neoplasm

Interventions

DRUG: LUTATHERA® (Lutetium Lu 177 dotatate)

Sponsor

Nationwide Children's Hospital